Virus-based immunotherapy of glioblastoma

M Martikainen, M Essand - Cancers, 2019 - mdpi.com
Glioblastoma (GBM) is the most common type of primary brain tumor in adults. Despite
recent advances in cancer therapy, including the breakthrough of immunotherapy, the …

The human cytomegalovirus, from oncomodulation to oncogenesis

G Herbein - Viruses, 2018 - mdpi.com
Besides its well-described impact in immunosuppressed patients, the role of human
cytomegalovirus (HCMV) in the pathogenesis of cancer has been more recently …

Presence of the human cytomegalovirus in glioblastomas—A systematic review

I Peredo-Harvey, A Rahbar, C Söderberg-Nauclér - Cancers, 2021 - mdpi.com
Simple Summary Whether the human cytomegalovirus (HCMV) is present in samples
obtained from patients with glioblastoma (GBM) has been a matter under debate during the …

Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells

A Tanne, LR Muniz, A Puzio-Kuter… - Proceedings of the …, 2015 - National Acad Sciences
Recent studies have demonstrated abundant transcription of a set of noncoding RNAs
(ncRNAs) preferentially within tumors as opposed to normal tissue. Using an approach from …

Epstein–Barr virus in gliomas: cause, association, or artifact?

S Akhtar, S Vranic, FS Cyprian… - Frontiers in oncology, 2018 - frontiersin.org
Gliomas are the most common malignant brain tumors and account for around 60% of all
primary central nervous system cancers. Glioblastoma multiforme (GBM) is a grade IV …

A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus-tumor association

MJ Strong, E Blanchard, Z Lin, CA Morris… - Acta neuropathologica …, 2016 - Springer
Next generation sequencing (NGS) can globally interrogate the genetic composition of
biological samples in an unbiased yet sensitive manner. The objective of this study was to …

IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma

M Martikainen, M Ramachandran, R Lugano… - Molecular Therapy …, 2021 - cell.com
Oncolytic virotherapy holds promise of effective immunotherapy against otherwise
nonresponsive cancers such as glioblastoma. Our previous findings have shown that …

Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics

P Baumgarten, M Michaelis, F Rothweiler… - Neuro …, 2014 - academic.oup.com
Background Experimental findings have suggested that human cytomegalovirus (HCMV)
infection of tumor cells may exert oncomodulatory effects that enhance tumor malignancy …

Association between cytomegalovirus infection and neurological disorders: A systematic review

S Sanami, S Shamsabadi, A Dayhimi… - Reviews in Medical …, 2024 - Wiley Online Library
Cytomegalovirus (CMV) belongs to the Herpesviridae family and is also known as human
herpesvirus type 5. It is a common virus that usually doesn't cause any symptoms in healthy …

Immunotherapeutic challenges for pediatric cancers

B Hutzen, M Ghonime, J Lee, ER Mardis… - Molecular Therapy …, 2019 - cell.com
Solid tumors contain a mixture of malignant cells and non-malignant infiltrating cells that
often create a chronic inflammatory and immunosuppressive microenvironment that restricts …